Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Kristine Abo, M.D.,Ph.D.

Concepts (22)

Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Kristine Abo's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Kristine Abo has written about over time.
Acetylation, 1 publications between 2017 and 2017, average publication date August 2017. Adrenergic beta-1 Receptor Agonists, 1 publications between 2017 and 2017, average publication date August 2017. Adrenergic beta-Antagonists, 1 publications between 2017 and 2017, average publication date August 2017. Albuterol, 1 publications between 2017 and 2017, average publication date August 2017. alpha-Synuclein, 1 publications between 2017 and 2017, average publication date August 2017. Cell Line, Tumor, 1 publications between 2017 and 2017, average publication date August 2017. Enhancer Elements, Genetic, 1 publications between 2017 and 2017, average publication date August 2017. Gene Expression Regulation, 1 publications between 2017 and 2017, average publication date August 2017. Histones, 1 publications between 2017 and 2017, average publication date August 2017. Ligands, 1 publications between 2017 and 2017, average publication date August 2017. Mice, 1 publications between 2017 and 2017, average publication date August 2017. Neuroprotective Agents, 1 publications between 2017 and 2017, average publication date August 2017. Norway, 1 publications between 2017 and 2017, average publication date August 2017. Parkinson Disease, 1 publications between 2017 and 2017, average publication date August 2017. Promoter Regions, Genetic, 1 publications between 2017 and 2017, average publication date August 2017. Propranolol, 1 publications between 2017 and 2017, average publication date August 2017. Receptors, Adrenergic, beta-2, 1 publications between 2017 and 2017, average publication date August 2017. Risk, 1 publications between 2017 and 2017, average publication date August 2017. Substantia Nigra, 1 publications between 2017 and 2017, average publication date August 2017. Transcription, Genetic, 1 publications between 2017 and 2017, average publication date August 2017.

To see the data from this visualization as text, click here.
Abo's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (22)
Explore
_
Co-Authors (5)
Explore
_
Similar People (59)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.